In a case-control study in the Chinese population, methylation of the IGSF4 gene promoter (containing 12 CpG sites) of thalassemia patients (n = 23) was significantly higher (p < 0.05) than that in healthy controls (n = 5). This evidence concerns the gene CADM1 and thalassemia.